Parkinson disease can lead to errors on driving testNovember 28, 2006ST. PAUL, Minn - People with Parkinson disease were more likely to make more safety mistakes during a driving test than people with no neurological disorders, according to a study published in the November 28, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology. The study involved an on-road driving test of 71 people with mild to moderate Parkinson disease who were current drivers and 147 people of similar age with no neurological disorders. While driving, the participants were given a verbal addition task that simulates the amount of distraction similar to having a conversation with a passenger or using a cell phone while driving. While distracted, 28 percent of those with Parkinson disease made more driving safety mistakes than they did when they were not distracted, compared to 16 percent of those who did not have Parkinson disease. Those with Parkinson who made more safety mistakes and had poorer ability to control their speed and steering due to effects of distraction also did worse on tests of memory, vision and balance and the ability to switch attention between competing tasks, and were more likely to have excessive daytime sleepiness. "The abilities of the people with Parkinson disease varied greatly, which in some ways is not surprising because this disease affects people very differently," said neurologist and principal investigator Ergun Uc, MD, of the University of Iowa and the Veterans Affairs Medical Center in Iowa City. "Clearly, Parkinson disease can affect the ability to drive, and that effect grows as the disease progresses. People with Parkinson disease should be aware of this potential decline in driving ability and their family and friends should also monitor it and then recheck periodically." Uc noted that the well-known motor problems caused by the disease - tremors and difficulty with movement - had less effect on driving ability than lesser known aspects of the disease such as effects on mental functioning, vision and sleep. American Academy of Neurology |
|||||||||||||||||||||
| Related Parkinson Disease Current Events and Parkinson Disease News Articles A balancing act in Parkinson's disease: Phosphorylation of alpha-synuclein Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Rochester-led Parkinson's study pays off again, 2 decades later Parkinson disease progresses more slowly in patients who have higher levels of urate, a chemical that at very high level is associated with gout, scientists have found. Pesticide exposure found to increase risk of Parkinson's disease The fertile soil of California's Central Valley has long made it famous as one of the nation's prime crop-growing regions. But it's not just the soil that allows for such productivity. Crops like potatoes, dry beans and tomatoes have long been protected from bugs and weeds by the fungicide maneb and the herbicide paraquat. Immune cells contribute to the development of Parkinson's disease Parkinson disease is a neurodegenerative disorder that impairs movement, balance, speech, and other functions. It is characterized by the loss of nerves in the brain that produce a substance known as dopamine. Lessons from yeast: A possible cure for Parkinson's disease? Parkinson disease (PD) is a debilitating and lethal neurodegenerative disease, for which there is currently no cure. It is caused by the progressive loss of nerve cells that produce the chemical dopamine and is characterized by the accumulation of abnormal aggregates of a protein called alpha-syn in these dopaminergic nerve cells. New Study Shows that Fetal Cells Transplanted into the Brain to Treat Parkinson's Disease May Not Function Long Term Neurons grafted into the brain of a patient with Parkinson's disease fourteen years ago have developed Lewy body pathology, the defining pathology for the disease, according to research by Jeffrey H. Kordower, PhD, and associates and published in the April 6 issue of Nature Medicine. Family study bolsters link between pesticides and Parkinson's For the first time, the association between Parkinson's disease and exposure to pesticides has been shown in patients with the neurological disorder compared with their unaffected relatives, according to a study in the online open access journal BMC Neurology. Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition. PINK1 protects from Parkinson's Parkinson disease (PD) is a common neurodegenerative disease characterized by the selective loss of midbrain dopaminergic neurons. Researchers identify protein pathway involved in Parkinson disease development Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. More Parkinson Disease Current Events and Parkinson Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||